A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer

2010 ◽  
Vol 66 (5) ◽  
pp. 987-992 ◽  
Author(s):  
Manabu Shiozawa ◽  
Makoto Akaike ◽  
Nobuhiro Sugano ◽  
Kazuhito Tsuchida ◽  
Naoto Yamamoto ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Combination Therapy ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Phase Ii Study

Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer

2003 ◽  
Vol 52 (2) ◽  
pp. 125-130 ◽  
Author(s):  
Tadamichi Denda ◽  
Tomonori Ambo ◽  
Atsushi Ohtsu ◽  
Yasuhide Yamada ◽  
Kuniaki Shirao ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Combination Therapy ◽  
Mitomycin C ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Phase Ii Study

scholarly journals Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer

2006 ◽  
Vol 17 (6) ◽  
pp. 968-973 ◽  
Author(s):  
A. Goto ◽  
Y. Yamada ◽  
H. Yasui ◽  
K. Kato ◽  
T. Hamaguchi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Combination Therapy ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Phase Ii Study

scholarly journals Cetuximab plus FOLFOX-4 in Untreated Patients with Advanced Colorectal Cancer: A Gruppo Oncologico dell’Italia Meridionale Multicenter Phase II Study

Oncology ◽  
2010 ◽  
Vol 79 (5-6) ◽  
pp. 415-422 ◽  
Author(s):  
Giuseppe Colucci ◽  
Francesco Giuliani ◽  
Carlo Garufi ◽  
Rodolfo Mattioli ◽  
Luigi Manzione ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Phase Ii Study ◽  
Multicenter Phase
Sign in / Sign up

Export Citation Format

Share Document